StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio r&d expenses

Research and development expenses are spending on new products and technology.

Palisade Bio's R&D Expenses for the twelve months ending Jun 30, 2026 was $19.57M, up 5.1% year over year. For fiscal 2025 it was $10.19M, down 36.3% from the year before. Over ten years it grew -2.1% a year on average. The highest annual figure on record is $16.00M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.19M-36.3%
FY2024Dec 31, 2024$16.00M+132.1%
FY2023Dec 31, 2023$6.89M+5.3%
FY2022Dec 31, 2022$6.55M+169.4%
FY2021Dec 31, 2021$2.43M-21.6%
FY2020Dec 31, 2020$3.10M-23.7%
FY2019Dec 31, 2019$4.06M+2.6%
FY2018Dec 31, 2018$3.96M-51.1%
FY2017Dec 31, 2017$8.10M-38.5%
FY2016Dec 31, 2016$13.16M+4.1%
FY2015Dec 31, 2015$12.64M+51.1%
FY2014Dec 31, 2014$8.36M+14.8%
FY2013Dec 31, 2013$7.29M+19.3%
FY2012Dec 31, 2012$6.11M-17.0%
FY2011Dec 31, 2011$7.35M-19.7%
FY2010Dec 31, 2010$9.16M+71.4%
FY2009Dec 31, 2009$5.35M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.00M+258.2%
Q1 FY2026Mar 31, 2026$6.00M+531.6%
Q4 FY2025Dec 31, 2025$6.17M–
Q3 FY2025Sep 30, 2025$1.39M-91.3%
Q2 FY2025Jun 30, 2025$1.68M-36.3%
Q1 FY2025Mar 31, 2025$950.00K-57.1%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$16.00M+660.5%
Q2 FY2024Jun 30, 2024$2.63M+20.7%
Q1 FY2024Mar 31, 2024$2.21M+78.4%
Q4 FY2023Dec 31, 2023$362.00K-84.5%
Q3 FY2023Sep 30, 2023$2.10M+9.1%
Q2 FY2023Jun 30, 2023$2.18M+65.3%
Q1 FY2023Mar 31, 2023$1.24M+29.4%
Q4 FY2022Dec 31, 2022$2.34M+192.9%
Q3 FY2022Sep 30, 2022$1.93M+209.0%
Q2 FY2022Jun 30, 2022$1.32M+319.4%
Q1 FY2022Mar 31, 2022$959.00K+38.6%
Q4 FY2021Dec 31, 2021$800.00K+1.9%
Q3 FY2021Sep 30, 2021$624.00K+51.5%
Q2 FY2021Jun 30, 2021$314.00K-51.7%
Q1 FY2021Mar 31, 2021$692.00K-0.7%
Q4 FY2020Dec 31, 2020$785.00K+2.3%
Q3 FY2020Sep 30, 2020$412.00K-50.1%
Q2 FY2020Jun 30, 2020$650.00K-31.9%
Q1 FY2020Mar 31, 2020$696.89K-54.0%
Q4 FY2019Dec 31, 2019$767.05K-12.7%
Q3 FY2019Sep 30, 2019$825.49K-8.0%
Q2 FY2019Jun 30, 2019$954.45K-5.9%
Q1 FY2019Mar 31, 2019$1.51M+29.5%
Q4 FY2018Dec 31, 2018$878.87K-28.3%
Q3 FY2018Sep 30, 2018$897.10K-35.2%
Q2 FY2018Jun 30, 2018$1.01M-60.7%
Q1 FY2018Mar 31, 2018$1.17M-59.7%
Q4 FY2017Dec 31, 2017$1.23M-69.6%
Q3 FY2017Sep 30, 2017$1.38M-61.5%
Q2 FY2017Jun 30, 2017$2.59M–
Q1 FY2017Mar 31, 2017$2.90M–
Q4 FY2016Dec 31, 2016$4.03M–
Q3 FY2016Sep 30, 2016$3.59M–

More Palisade Bio figures

See a number that looks wrong?